Stay updated on Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Sign up to get notified when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.

Latest updates to the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedThe page footer’s interface revision indicator was updated from v3.5.2 to v3.5.3, reflecting a site/version change rather than an update to the underlying study record.SummaryDifference0.1%

- Check27 days agoChange DetectedAdded Revision: v3.5.2; Deleted Revision: v3.5.0.SummaryDifference0.1%

- Check56 days agoChange DetectedA new revision entry v3.5.0 was added to the record history, and the previous revision v3.4.3 was removed.SummaryDifference0.1%

- Check71 days agoChange DetectedRevision v3.4.3 was added to the page history. Revision v3.4.2 was removed from the history.SummaryDifference0.1%

- Check78 days agoChange DetectedThe Record History shows multiple submissions updating study status, recruitment status, and core study details such as eligibility criteria, locations, and outcome measures.SummaryDifference0.1%

- Check92 days agoChange DetectedThe page history now includes revision v3.4.2 and removes the previous revision v3.4.1.SummaryDifference0.1%

Stay in the know with updates to Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Mesenchymal Stromal Cells vs Best Available Therapy in GVHD: Clinical Trial page.